ABSCI CORP (ABSI)
(Delayed Data from NSDQ)
$2.95 USD
-0.04 (-1.34%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $2.91 -0.04 (-1.36%) 6:42 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Absci Corporation has a PEG ratio of 6.75 compared to the Medical - Biomedical and Genetics industry's PEG ratio of 1.09.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ABSI 2.95 -0.04(-1.34%)
Will ABSI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ABSI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABSI
Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates
Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Beats Revenue Estimates
ABSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains?
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
Absci Corporation (ABSI) Reports Q3 Loss, Misses Revenue Estimates
Other News for ABSI
Vanguard Group Inc's Strategic Acquisition of Absci Corp Shares
Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on ...
Insider Buying: Andreas Busch Acquires 50,000 Shares of Absci Corp (ABSI)
Absci (ABSI) Receives Price Target Adjustment by Morgan Stanley | ABSI Stock News
Absci (ABSI) Price Target Reduced by Morgan Stanley Amid Public Offering